Creso Pharma On Verge of Acquiring Canadian /Columbian Outfit “Kunna”

Creso believe that Columbian medicinal cannabis quotas will serve 44% of global demand. Creso Pharma (ASX: CPH) has reported its nearly completed due diligence to acquire Kunna Canada and its wholly-owned Colombian medicinal cannabis subsidiary Kunna SAS, with the transaction due to wind up next month.

Go to Source

Powered by WPeMatico